Latest News about Gilead Sciences, Inc/
Recent news which mentions Gilead Sciences, Inc/
Gilead's remdesivir wins FDA's first full approval as Covid drug
October 22, 2020
From Business Journals
From Business Journals
Gilead pays $97M to settle charity foundation case, claims no wrongdoing
September 25, 2020
From Business Journals
Gilead to buy East Coast breast cancer-focused biotech in $21 billion deal
September 14, 2020
From Business Journals
With fresh $155M round, Gilead's former top scientist moves forward with cancer-fighting startup
August 24, 2020
From Business Journals
Big-deal Gilead rheumatoid arthritis drug rejected by FDA
August 19, 2020
From Business Journals
Kansas plant will produce Covid-19 drug that is in short supply
August 10, 2020
From Business Journals
Under pressure to boost production of Covid-19 drug remdesivir, Gilead inks pact with Pfizer
August 07, 2020
From Business Journals
From Business Journals
Biotech's surge pushes Bay Area companies — including a Covid drug hopeful — toward collective $1 billion in fresh funds
July 06, 2020
From Business Journals
Mylan to manufacture Covid-19 treatment for India
July 06, 2020
From Business Journals
TBJ Plus: Raleigh restaurant celebrates 60 years; NC hot on Airbnb for July Fourth; Coronavirus drug to cost $3,120
June 29, 2020
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Gilead's latest Covid study finds mixed results for 'moderate' patients — and that may be good
June 01, 2020
From Business Journals
From Business Journals
Gilead's drug pricing in the crosshairs again in wake of OK to use remdesivir against Covid-19
May 04, 2020
From Business Journals
FDA clears Gilead's Covid-fighting drug remdesivir
May 01, 2020
From Business Journals
UAB-developed drug posts promising results in trial
April 30, 2020
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.